Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRioRTI pregabalin for acute whiplash
ACTRN12624001359527Phase 3Recruiting
- Sponsor
- The University of Queensland
- Start
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial in Whiplash Associated Disorder (WAD) comparing Pregabalin with Placebo (2 arms). Primary endpoint: Neck pain intensity. Started Sep 2025; status: recruiting.
02
Drugs
pregabalin
03
Conditions
Whiplash Associated Disorder (WAD)
Beyond the preview
Go deeper on ACTRN12624001359527.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12624001359527.